DK404187A - Fremgangsmaade til fremstilling af thiazolderivater - Google Patents

Fremgangsmaade til fremstilling af thiazolderivater

Info

Publication number: DK404187A
Authority: DK; Denmark
Prior art keywords: thiazold; derivatives; procedure; preparation; thiazold derivatives
Prior art date: 1986-08-05

Application number

DK404187A

Other languages

English (en)

Other versions

DK404187D0 (da

DK175022B1 (da

Inventor

Peter Bod

Kalman Harsanyi

Bela Hegedues

Erik Bogsch

Eva Fekecs

Imre Peter

Zsuzsanna Aracs

Sandor Miszori

Maria Stiller

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-05

Filing date

1987-08-03

Publication date

1988-02-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10963778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK404187(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-08-03 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

1987-08-03 Publication of DK404187D0 publication Critical patent/DK404187D0/da

1988-02-06 Publication of DK404187A publication Critical patent/DK404187A/da

2004-04-26 Application granted granted Critical

2004-04-26 Publication of DK175022B1 publication Critical patent/DK175022B1/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK198704041A 1986-08-05 1987-08-03 Fremgangsmåde til fremstilling af en morfologisk homogen polymorf af Famotidin form B DK175022B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU863370A HU196775B (en)	1986-08-05	1986-08-05	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
HU337086		1986-08-05

Publications (3)

Publication Number	Publication Date
DK404187D0 DK404187D0 (da)	1987-08-03
DK404187A true DK404187A (da)	1988-02-06
DK175022B1 DK175022B1 (da)	2004-04-26

Family

ID=10963778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198704041A DK175022B1 (da)	1986-08-05	1987-08-03	Fremgangsmåde til fremstilling af en morfologisk homogen polymorf af Famotidin form B

Country Status (18)

Country	Link
US (3)	US4894459A (da)
EP (1)	EP0256747B2 (da)
JP (2)	JP2644234B2 (da)
KR (1)	KR940003954B1 (da)
CN (1)	CN1024275C (da)
AR (1)	AR243175A1 (da)
AT (1)	ATE82274T1 (da)
AU (1)	AU604040B2 (da)
BG (1)	BG60496B2 (da)
CA (1)	CA1265809A (da)
CS (1)	CS268188B2 (da)
DE (2)	DE3782576T3 (da)
DK (1)	DK175022B1 (da)
FI (1)	FI89917C (da)
GR (1)	GR871216B (da)
HU (1)	HU196775B (da)
PH (1)	PH24069A (da)
PT (1)	PT85473B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL86330A0 (en) *	1987-06-22	1988-11-15	Marga Investigacion	Famotidine polymorphic forms and their preparation
DE69429119T2 (de) *	1993-07-09	2002-07-18	R.P. Scherer Corp., Troy	Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US6939873B2 (en) *	2000-07-26	2005-09-06	Taro Pharmaceuticals Industries Limited	Non-sedating barbituric acid derivatives
US7683071B2 (en) *	2000-07-26	2010-03-23	Taro Pharmaceuticals Industries Ltd.	Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6756379B2 (en)	2001-07-26	2004-06-29	Taro Pharmaceutical Industries Ltd.	Non-sedating barbiturate compounds as neuroprotective agents
TWI353979B (en) *	2002-04-10	2011-12-11	Nippon Zoki Pharmaceutical Co	Novel crystal form of 5-hydroxy-1-methylhydantoin
CA2426122A1 (en) *	2002-05-02	2003-11-02	M/S Tonira Pharma Limited	A process for the preparation of a combination of famotidine polymorphis a and b
TW200409746A (en) *	2002-07-26	2004-06-16	Theravance Inc	Crystalline β2 adrenergic receptor agonist
BR0317289A (pt) *	2002-12-11	2005-11-08	Taro Pharma Ind	Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
TW200510277A (en) *	2003-05-27	2005-03-16	Theravance Inc	Crystalline form of β2-adrenergic receptor agonist
CA2572797A1 (en) *	2004-07-02	2006-01-12	Daniella Gutman	A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
US8067451B2 (en) *	2006-07-18	2011-11-29	Horizon Pharma Usa, Inc.	Methods and medicaments for administration of ibuprofen
WO2007012019A2 (en) *	2005-07-18	2007-01-25	Horizon Therapeutics, Inc.	Medicaments containing famotidine and ibuprofen and administration of same
US20080021078A1 (en) *	2006-07-18	2008-01-24	Horizon Therapeutics, Inc.	Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) *	2006-07-18	2008-01-24	Horizon Therapeutics, Inc.	Unit dose form for administration of ibuprofen
PT2043637E (pt)	2006-07-18	2012-04-12	Horizon Pharma Usa Inc	Métodos e medicamentos para administração de ibuprofeno
US8067033B2 (en)	2007-11-30	2011-11-29	Horizon Pharma Usa, Inc.	Stable compositions of famotidine and ibuprofen
US20100297224A1 (en) *	2006-08-31	2010-11-25	Horizon Therapeutics, Inc.	NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
US7718649B1 (en)	2006-11-10	2010-05-18	Pisgah Labs, Inc.	Physical states of a pharmaceutical drug substance
US8039461B1 (en)	2006-11-10	2011-10-18	Pisgah Laboratories, Inc.	Physical states of a pharmaceutical drug substance
WO2008066704A2 (en) *	2006-11-14	2008-06-05	Taro Pharmaceuticals North America, Inc.	Method of improving bioavailability for non-sedating barbiturates
US8883863B1 (en)	2008-04-03	2014-11-11	Pisgah Laboratories, Inc.	Safety of psuedoephedrine drug products
TW201011043A (en) *	2008-06-20	2010-03-16	Chugai Pharmaceutical Co Ltd	Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
WO2015163832A1 (en)	2014-04-25	2015-10-29	Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş.	An ibuprofen and famotidine combined composition having improved stability
TR201618765A2 (tr)	2016-12-16	2018-07-23	Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi	Ağrı ve enflamasyonun tedavisi için steroid olmayan anti-enflamatuvar ilaçlar ve H2 reseptörü antagonisti kombinasyonları.
BR112023000598A2 (pt)	2020-07-15	2023-01-31	Schabar Res Associates Llc	Composições de dose oral unitária composta de ibuprofeno e famotidina para o tratamento da dor aguda e redução da gravidade e/ou risco de azia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1543238A (en) *	1976-09-21	1979-03-28	Smith Kline French Lab	Polymorph of cimetidine
JPS6056143B2 (ja) *	1979-08-02	1985-12-09	山之内製薬株式会社	アミジン誘導体ならびにその製造法
JPS5655383A (en) *	1979-10-12	1981-05-15	Yamanouchi Pharmaceut Co Ltd	Amizine derivative and its preparation
HU185457B (en) *	1981-09-25	1985-02-28	Richter Gedeon Vegyeszet	Process for preparating cimetidine-z
US4496737A (en) *	1982-09-27	1985-01-29	Merck & Co., Inc.	Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) *	1983-06-07	1984-12-21	Yamanouchi Pharmaceut Co Ltd	新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) *	1985-09-11	1988-03-28	Richter Gedeon Vegyeszet	Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) *	1986-06-20	1987-12-23	Uriach & Cia Sa J	Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
GB8618847D0 (en) *	1986-08-01	1986-09-10	Smith Kline French Lab	Pharmaceutical formulations
IL86330A0 (en) *	1987-06-22	1988-11-15	Marga Investigacion	Famotidine polymorphic forms and their preparation

1986
- 1986-08-05 HU HU863370A patent/HU196775B/hu unknown
1987
- 1987-07-29 GR GR871216A patent/GR871216B/el unknown
- 1987-07-30 PH PH35602A patent/PH24069A/en unknown
- 1987-08-03 FI FI873346A patent/FI89917C/fi not_active IP Right Cessation
- 1987-08-03 DK DK198704041A patent/DK175022B1/da not_active IP Right Cessation
- 1987-08-03 PT PT85473A patent/PT85473B/pt unknown
- 1987-08-04 DE DE3782576T patent/DE3782576T3/de not_active Expired - Lifetime
- 1987-08-04 JP JP62193855A patent/JP2644234B2/ja not_active Expired - Lifetime
- 1987-08-04 EP EP87306882A patent/EP0256747B2/en not_active Expired - Lifetime
- 1987-08-04 CN CN87105373A patent/CN1024275C/zh not_active Expired - Lifetime
- 1987-08-04 CS CS875799A patent/CS268188B2/cs not_active IP Right Cessation
- 1987-08-04 AU AU76542/87A patent/AU604040B2/en not_active Expired
- 1987-08-04 KR KR1019870008563A patent/KR940003954B1/ko not_active Expired - Fee Related
- 1987-08-04 AT AT87306882T patent/ATE82274T1/de not_active IP Right Cessation
- 1987-08-04 AR AR87308333A patent/AR243175A1/es active
- 1987-08-04 CA CA000543728A patent/CA1265809A/en not_active Expired - Lifetime
- 1987-08-04 US US07/081,423 patent/US4894459A/en not_active Expired - Lifetime
- 1987-08-04 DE DE198787306882T patent/DE256747T1/de active Pending
1990
- 1990-04-27 US US07/515,191 patent/US5120850A/en not_active Expired - Lifetime
1991
- 1991-07-11 US US07/728,805 patent/US5128477A/en not_active Expired - Lifetime
1994
- 1994-01-18 BG BG098384A patent/BG60496B2/bg unknown
- 1994-08-22 JP JP6196865A patent/JP2708715B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH07316141A (ja)	1995-12-05
DE3782576T3 (de)	2002-08-08
DE3782576D1 (de)	1992-12-17
DE3782576T2 (de)	1993-03-25
JP2644234B2 (ja)	1997-08-25
US4894459A (en)	1990-01-16
FI873346L (fi)	1988-02-06
DK404187D0 (da)	1987-08-03
AR243175A1 (es)	1993-07-30
EP0256747B2 (en)	2001-11-28
PT85473B (pt)	1990-06-29
FI89917C (fi)	1993-12-10
AU604040B2 (en)	1990-12-06
CN87105373A (zh)	1988-06-08
FI89917B (fi)	1993-08-31
ATE82274T1 (de)	1992-11-15
PH24069A (en)	1990-03-05
US5128477A (en)	1992-07-07
FI873346A0 (fi)	1987-08-03
KR940003954B1 (ko)	1994-05-09
KR880002847A (ko)	1988-05-11
BG60496B2 (bg)	1995-05-31
CN1024275C (zh)	1994-04-20
HUT45240A (en)	1988-06-28
US5120850A (en)	1992-06-09
GR871216B (en)	1987-11-19
HU196775B (en)	1989-01-30
CA1265809A (en)	1990-02-13
EP0256747B1 (en)	1992-11-11
EP0256747A1 (en)	1988-02-24
JPS6399065A (ja)	1988-04-30
JP2708715B2 (ja)	1998-02-04
CS268188B2 (en)	1990-03-14
AU7654287A (en)	1988-02-11
CS579987A2 (en)	1989-04-14
DK175022B1 (da)	2004-04-26
DE256747T1 (de)	1988-11-24
PT85473A (en)	1987-09-01

Publication	Publication Date	Title
DK404187A (da)	1988-02-06	Fremgangsmaade til fremstilling af thiazolderivater
DK86193D0 (da)	1993-07-21	Fremgangsmaade til fremstilling af trifluorbenzoesyrederivater
DK250689D0 (da)	1989-05-23	Fremgangsmaade til fremstilling af napthalenderivater
DK165984C (da)	1993-07-19	Fremgangsmaade til fremstilling af sphingosinderivater
DK375987D0 (da)	1987-07-17	Fremgangsmaade til fremstilling af cycloalkyl-sub-stituerede 4-pyridyl derivater
DK30489A (da)	1989-07-27	Fremgangsmaade til fremstilling af pyranderivater
DK537687A (da)	1988-04-15	Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK516286A (da)	1987-05-02	Fremgangsmaade til fremstilling af oxazolderivater
DK314988A (da)	1988-12-12	Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK28788A (da)	1988-07-24	Fremgangsmaade til fremstilling af alkansulfonamider
DK601489D0 (da)	1989-11-29	Fremgangsmaade til fremstilling af alkansulfonamider
DK184687D0 (da)	1987-04-10	Fremgangsmaade til fremstilling af diacetonesorbose
DK143889A (da)	1989-09-27	Fremgangsmaade til fremstilling af naphthalenderivater
DK158224C (da)	1990-09-24	Fremgangsmaade til fremstilling af indolderivater
DK533287D0 (da)	1987-10-12	Fremgangsmaade til fremstilling af azetidinoner
DK293589A (da)	1989-12-17	Fremgangsmaade til fremstiling af lactolderivater
DK558487D0 (da)	1987-10-23	Fremgangsmaade til fremstilling af moertel
DK599689A (da)	1990-05-30	Fremgangsmaade til fremstilling af naphthalenderivater
DK184789A (da)	1989-11-11	Fremgangsmaade til fremstilling af naphthalenderivater
DK234687D0 (da)	1987-05-08	Fremgangsmaade til fremstilling af ribitylxylidin
DK256786A (da)	1987-12-01	Fremgangsmaade til fremstilling af triazolderivater
DK291785A (da)	1985-12-30	Fremgangsmaade til fremstilling af iminderivater
DK26888D0 (da)	1988-01-21	Fremgangmsaade til fremstilling af diaminoalkanderivater
DK162789D0 (da)	1989-04-05	Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK64085A (da)	1985-08-14	Fremgangsmaade til fremstilling af imidazolderivater

Legal Events

Date	Code	Title	Description
2007-08-20	PUP	Patent expired